Cameron J L, Pitt H A, Yeo C J, Lillemoe K D, Kaufman H S, Coleman J
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Ann Surg. 1993 May;217(5):430-5; discussion 435-8. doi: 10.1097/00000658-199305010-00002.
A review of mortality and morbidity for pancreaticoduodenectomy was performed for 145 consecutive patients who underwent the operative procedure between 1988 and 1991.
In the past, pancreaticoduodenectomy has carried a high hospital morbidity and mortality. During the 1970s, many considered that the operation should be abandoned. Recent data, however, suggest that a marked drop in both morbidity and mortality have occurred for this operative procedure.
Among the 145 consecutive patients who underwent pancreaticoduodenectomy, 108 patients were 69 years of age or younger, and 37 were 70 years of age or older. Four patients were 80 years of age or older. One hundred and seven patients had a malignant neoplasm, whereas 38 patients had benign disease. There were no significant differences in preoperative risk factors when the younger and older, and benign disease and malignant disease groups were compared.
Mean operative time was 7.3 hours. Median blood loss was 0, indicating that more than one-half of the patients underwent pancreaticoduodenectomies without blood transfusions. There were no significant differences in postoperative complications when the younger and older, and benign disease and malignant disease groups were compared. There was no hospital or 30-day mortality.
With appropriate preoperative selection, virtually any patient in any age group, with benign or malignant disease, can undergo pancreaticoduodenectomy with minimal risk of hospital mortality.
对1988年至1991年间连续接受胰十二指肠切除术的145例患者的死亡率和发病率进行回顾性研究。
过去,胰十二指肠切除术的医院发病率和死亡率一直很高。在20世纪70年代,许多人认为该手术应该被放弃。然而,最近的数据表明,该手术的发病率和死亡率都有显著下降。
在连续接受胰十二指肠切除术的145例患者中,108例患者年龄在69岁及以下,37例患者年龄在70岁及以上。4例患者年龄在80岁及以上。107例患者患有恶性肿瘤,而38例患者患有良性疾病。比较年轻组和老年组以及良性疾病组和恶性疾病组的术前危险因素,无显著差异。
平均手术时间为7.3小时。中位失血量为0,这表明超过一半的患者在未输血的情况下接受了胰十二指肠切除术。比较年轻组和老年组以及良性疾病组和恶性疾病组的术后并发症,无显著差异。无医院死亡或30天死亡率。
通过适当的术前选择,几乎任何年龄组、患有良性或恶性疾病的患者都可以接受胰十二指肠切除术,且医院死亡率风险最小。